SCHEMBL17636712

SCHEMBL17636712

c1ccc(-c2nnc(-c3ccccc3)n2-c2cccc3c4ccccc4n(-c4cccc(-n5c6ccccc6c6ccccc65)c4)c23)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
OPRD1 P41143 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HIF1A Q16665 1/20 0.41
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
AVPR1A P37288 1/20 0.40
ALDH1A1 P00352 2/20 0.39
AKT1 P31749 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18109216 0.93 KDM4E (0.49) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL21532719 0.91 KDM4E (0.40) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL17636640 0.88 MAPT (0.46) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL21532408 0.87 KDM4E (0.39) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL14681152 0.87 KDM4E (0.55) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL17636876 0.87 SMN1; SMN2 (0.41) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL17636684 0.86 KDM4E (0.45) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL21532332 0.86 KDM4E (0.33) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL21532693 0.86 KDM4E (0.33) KDM4EATML3MBTL1OPRD1SMN1; SMN2
SCHEMBL21532734 0.86 KDM4E (0.40) KDM4EATML3MBTL1OPRD1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-9960365-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160093811-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 KDM4E 2877/4885ATM 1091/4885L3MBTL1 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.